Anthem Biosciences profitability ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026

Returns
	19.5%	19.5%
	17.3%	17.3%
	22.6%	22.6%
	22.4%	23.3%
Margins
	39.6%	39.3%
	32.9%	32.9%
	39.1%	38.8%
	28.8%	27.9%
	29.8%	29.8%
Additional
	26.4%	28.2%
	19.5%	19.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ANTHEM₹805.70

Anthem Biosciences Ltd.

· Pharma & Health

₹ CrorePeersSYNGENE DIVISLAB GLAXO AJANTPHARM IPCALAB ABBOTINDIA MEDANTA GLENMARKMcap ₹45,257 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY26 31/03/2026	Last 12M 30/06/2026
Returns
Return on Common Equity	19.45	19.45
Return on Assets	17.26	17.26
Return on Capital Employed	22.55	22.55
Return on Invested Capital	23.31	22.38
Margins
EBITDA Margin	39.25	39.60
Operating Margin	32.94	32.94
Pretax Margin	38.80	39.08
Net Income Margin	27.86	28.76
FCF Margin	29.81	29.81
Additional
Effective Tax Rate	28.20	26.40
Sustainable Growth Rate	19.45	19.45

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.